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Abstract

The thesis entitled “Design, Synthesis, Conformational Analysis and Biological Studies of Peptides Containing Sugar Amino Acids, Furan Amino Acids and Studies Directed Towards the Total Synthesis of Neopeltolide” consists of three chapters. CHAPTER I: Describes the design, synthesis and conformational analysis of furanoid sugar amino acids based peptides. This chapter is divided into two parts: PART-A: Deals with the design, synthesis and conformational analysis of peptides containing furanoid sugar amino acids attached to dipeptides from natural amino acids. PART-B: Deals with the design, synthesis and conformational analysis of furanoid sugar amino acids based cyclic peptides stabilized by hydrogen bonding. CHAPTER II: Deals with the design, synthesis and biological evaluation of novel cyclic cationic peptides containing furan amino acids. This chapter is divided into two parts: PART-A: Deals with the design, synthesis and biological studies of cationic cyclic heterooligomers of furan amino acids. PART-B: Deals with the design, synthesis and biological studies of cationic cyclic homooligomers of trisubstituted furan amino acid. CHAPTER III: Describes the studies directed towards the total synthesis of Neopeltolide. CHAPTER-I PART-A: Design, Synthesis and conformational analysis of peptides containing furanoid sugar amino acids attached to dipeptides from natural amino acids. The usefulness of sugar amino acids as conformationally constrained multifunctional scaffolds in peptidomimetic studies has been amply demonstrated by many researchers worldwide. Besides, they have also emerged as an important class of synthetic monomers leading to many de novo oligomeric libraries. We have shown earlier that the linear tetramer of a glucose-derived furanoid sugar amino acid (Gaa) had a well-defined structure in CDCl3 with repeating β-turns, each involving a 10-membered ring structure with intramolecular hydrogen bonds between NHi  C=Oi2. In the present work, we have studied the conformational tolerance of the structure of Gaa-homooligomers by replacing alternate Gaa units with dipeptides from natural amino acids that gave peptides 1, 2 and 3 with repeating Gaa-Leu-Val units (Figure 1). 16 
Figure 1 Our synthesis started with methyl N-Boc-6-amino-2,5-anhydro-3,4-di-O-benzyl-6- deoxy-D-gluconate (Gaa) 13, which was prepared from D-mannitol 4 following reported procedure. Scheme 1 delineates the synthesis. Scheme 1 BocHN NH O HN O O BnO OBnHN O NH O OMe O BocHN O BnO OBnHN O NH O HN O O BnO OBnHN O NH O OMe O BocHN NH O HN O O BnO OBnHN O NH O HN O O BnO OBnHN O NH O OMe O 123 HO OH OHOH OH OH O O O O 4 5 OBnOBn ii) NaH, BnBr, TBAI (cat.), THF, 0 °C to rt, 3 h, 85% i) 2,2 DMP, PTSA (cat.), DMF, rt, 16 h, 52% TsO O OH O OBn OBn N3 O OH O OBn OBn p- TsCl, Et3N, DMAP (cat.) CH2Cl2, 0 °C to rt, 4 h, 91% NaN3, DMF 80 °C, 3 h, 95% 7 8 HO O OH O OBn OBn dil.HCl / MeOH 0 °C to rt, 4 h, 66% 6 TsO N3 OH OH OBn OBn p- TsCl, DMAP (cat.) Py, 0 °C to rt, 5 h K2CO3, MeOH 0 °C to rt, 12 h, 75% dil.HCl, MeOH 0 °C to rt, 5 h, 75% O OBn BnO N3 OH O OBn BnO BocHN OH i) PDC, DMF, 0 oC to rt, 12 h O OBn BnO BocHN OMe O HO N3 OH OH OBn OBn ii) CH2N2 / ether, 0 °C i) TPP, MeOH, rt, 4 h ii) Boc2O, rt, 12 h 80% 77% 9 10 11 12 13 17 
Saponification of 13 with LiOH.H2O in THF:MeOH:H2O (3:1:1) gave the carboxylic acid 14. The coupling between 14 and H-Leu-Val-OMe under the standard peptide coupling conditions using EDCI, HOBt and DIPEA in DCM gave the tripeptide Boc-Gaa(Bn2)-Leu- Val-OMe 15 in 70% yield (Scheme 2). Scheme 2 Now the tripeptide 15 was divided into three equimolar quantities. Saponification of one-third quantity separately with LiOH.H2O in THF:MeOH:H2O (3:1:1) gave the carboxylic acid 16. The two-third quantity of 15 was treated with trifluoroacetic acid in CH2Cl2 to give the Boc-deprotected product 17 (Scheme 3) Scheme 3 By coupling 17 with Boc-Leu-Val-OH and 16 with 17 under standard peptide coupling conditions with EDCI, HOBt we got 1 and 2, respectively in 85% and 70% yield (Scheme 4). O BnO OBnOH BocHN O LiOH.H2O, THF:MeOH:H2O (3:1:1) 0 °C to rt, 3 h CH2Cl2, 0 °C to rt, HOBt, EDCI, DIPEA 8 h, 70% H-Leu-Val-OMe O BnO OBnHNBocHN O NH O OMe O 14 15 13 16 15 LiOH.H2O, THF:MeOH:H2O (3:1:1) 0 °C, 2 h 0 °C, 1 h TFA, CH2Cl2 BocHN O BnO OBnHN O NH O OH O TFA:H2N O BnO OBnHN O NH O OMe O 17 18 
Scheme 4 Hexapeptide 2 was treated with trifluoroacetic acid in CH2Cl2 to give the Boc-deprotected product 18. By coupling 18 with Boc-Leu-Val-OH under standard peptide coupling conditions we got compound 3 in 70% yield (Scheme 5). Scheme 5 Conformational Studies Detailed NMR studies in CDCl3, DMSO-d6 and subsequent constrained MD simulations were employed for conformational studies. Solvent titration studies for 1, 2 and 3 were used to derive information about the involvement of the amide protons in intramolecular hydrogen bonds. HOBt, EDCI, DIPEA, Boc-Leu-Val-OH CH2Cl2, 0 °C to rt, 8 h BocHN NH O HN O O BnO OBnHN O NH O OMe O 1 85% 17 16 8 h, 70% HOBt, EDCI, DIPEA CH2Cl2, 0 °C to rt, + BocHN O BnO OBnHN O NH O HN O O BnO OBnHN O NH O OMe O 17 2 HOBt, EDCI, DIPEA, Boc-Leu-Val-OH CH2Cl2, 0 °C to rt, 8 h, 70% TFA:H2N O BnO OBnHN O NH O HN O O BnO OBnHN O NH O OMe O 18 2 TFA, CH2Cl2 0 °C, 1 h BocHN NH O HN O O BnO OBnHN O NH O HN O O BnO OBnHN O NH O OMe O 3 
Conformational analysis of the linear peptide 3 showed that it had a well-defined structure in CDCl3 with repeating  -turns, each involving a 10-membered ring structure with intramolecular hydrogen bonds between NHi  C=Oi2 (Fig. 2). The peptides 1 - 3 had conformational signatures very similar to those of homooligomers of Gaa with repetitive 19 
10/10/9-H-bonding patterns reminiscent of the helical structures of natural amino acid-containing peptides. 
Figure 2: Schematic representation of the H-bonding and long range nOe correlations observed for peptide 3. N H O N HO O O O N HN HO O O ON HN HO O O N HO O ON HO O H H H H H H H H H CH2Ph CH 2Ph CH2Ph CH2Ph H H
Figure 3: Stereoview of one of the low energy conformations of peptide 3 (for clarity the side-chains are not shown). In conclusion, although peptides with repeating Gaa-Leu-Val units did not nucleate the expected  -hairpin structures, such oligomeric assemblies with large propensity for helical structures can play significant roles in recognizing and binding to suitable receptors in biological systems. These efforts should permit the design of compounds that will successfully mimic the structures and functions of biopolymers. 20 
PART-B: Design, synthesis and conformational analysis of furanoid sugar amino acids based cyclic peptides stabilized by intramolecular H-bonding. In this part we decided to design and synthesize cyclic peptides that could exhibit secondary structure through intramolecular H-bonding. Herein we describe the synthesis of two cyclic peptides 19 and 20, containing sugar amino acids 21 (Saa1) and 23 (Saa2) respectively (Figure 4). These cyclic peptides were studied in detail for their conformational preferences. Figure 4 ONH HN NH O O O OHN NH NH O O O ONH HN NH O O O OHN NH NH O O O 19 20 O COOH BocHN O COOH BocHN 21 (Saa1) 22 (Saa2) 
Our synthesis started from (2S)-5-oxotetrahydro-2-furancarboxylic acid 24, which was prepared from L-glutamic acid 23, following the procedure described in Scheme 6. The compound 24 was reduced to alcohol 25, upon treatment with borane-dimethyl sulfide in anhydrous THF at 0 ºC to room temperature. Protection of the primary alcohol by using TrCl and Et3N with catalytic DMAP in DCM yielded 77% of 26. Lactone was selectively reduced to inseparable anomeric mixture of lactol 27 using DIBAL-H in 86% yield. Acetylation of anomeric alcohol using Ac2O, Et3N gave 28. Compound 28 was treated with trimethylsilyl cyanide in the presence of BF3:Et2O to give a diastereomeric mixture of the glycosyl cyanides 29, trityl deprotection also took place in the same step. Treatment of compound 29 with LiAlH4 in refluxing condition in THF resulted the primary amine, which was immediately protected with Boc2O to furnish 30 (: , 1:1) in 42% yield. Finally, two steps oxidation of primary hydroxyl 30, followed by treatment with CH2N2 resulted in the formation of 31 (85% yield). Saponification of 31 with LiOH.H2O in THF:MeOH:H2O (3:1:1) gave the sugar amino acid 21. The coupling between 21 and H-Leu-Val-OMe under the standard peptide 21 
coupling conditions using EDCI, HOBt and DIPEA in DCM gave the tripeptide Boc-SAA-Leu-Val-OMe 32 in 75% yield (Scheme 6). Scheme 6 Saponification of compound 32 was performed with LiOH.H2O in THF:MeOH:H2O (3:1:1) to furnish the free carboxyl group of 33. Next, the crude acid of 33 was treated with TFA in CH2Cl2, to give the TFA-salt 34. When the TFA-salt 34 was treated with pentaflourophenyl diphenylphosphinate (FDPP) and DIPEA in dry acetonitrile (10-3 M) at 0 C to room temperature, it underwent cyclodimerization reaction to give 19, the only isolated product in 60% yield (Scheme 7). . Scheme 7 O BocHN OH i) LiAlH4, ether, reflux ii) Boc2O, CH2Cl2 42 % of 30 + 30 other isomer 2 5 i) SO3-Py, Et3N, DMSO, CH2Cl2 ii) NaClO2, NaH2PO4.2H2O iii) CH2N2, Et2O 2-methyl-2-butene, tBuOH 85% O CO2Me BocHN 31 O CO2H O NH2 CO2H HO2C O O OH 23 24 25 NaNO2, H2SO4 H2O, 66% BH3:DMS THF, 0 ºC, 78% O O OTr O HO OTr 26 27 TrCl, Et3N, DMAP CH2Cl2, 77% DIBAL-H, CH2Cl2 -78 oC, 86% O AcO OTr O NC OH Ac2O, Et3N, DMAP CH2Cl2, 0 °C, 96% TMSCN, BF3:Et2O CH3CN, rt, 64% 28 29 0 °C to rt, 1 h THF:MeOH:H2O (3:1:1) LiOH.H2O CH2Cl2, 0 °C to rt, HOBt, EDCI, DIPEA 6 h, 75% H-Leu-Val-OMe O CO2H BocHN O BocHN O HN NH OMe O O 32 21 32 THF: MeOH: H2O TFA/CH2Cl2 FDPP, CH3CN 33 LiOH. H2O 0 °C, 2 h 60% 34 19 DIPEA, 72 h 0 °C, 3 h O BocHN O HN NH OH O O O TFAH2N O HN NH OH O O 22 
To synthesize another cyclic compound 20, we started from 35, which was prepared from D-fructose following the reported procedure. The Boc-protected furan amino acid 35 was hydrogenated in the presence of Pd/C (10%) in MeOH to obtain saturated tetrahydrofuran compound 36. The coupling between 36 and Boc-Leu-Val-OH under the standard peptide coupling conditions gave the diastereomeric tripeptides 32 and 37 (Scheme 8) which was separated by column chromatography. Scheme 8 Following the above-mentioned procedure 37 was cyclodimerised to furnish 20 in 55% yield (Scheme 9). Scheme 9 O BocHN O BocHN H2, Pd /C(10%), MeOH 91% 35 OH O OOH (Mixture of enantiomer) 36 (seperable diastereoisomer) O BocHN O HN NH OMe O O O BocHN O HN NH OMe O O + 32 37 CH2Cl2, 0 °C to rt, HOBt, EDCI, DIPEA Boc-Leu-Val-OH 6 h, 82% THF: MeOH: H2O TFA, CH2Cl2 FDPP, CH3CN 38 LiOH. H2O 0 °C, 2 h 55% 39 DIPEA, 72 h 0 °C, 3 h O BocHN O HN NH OH O O O TFAH2N O HNNH OH O O 37 20 
The NMR spectra of the cyclic peptides displayed symmetrical structures. Detailed NMR studies in CDCl3 and subsequent constrained MD simulations revealed that 19 and 20 displayed well-defined distorted “ - corner” structures where both LeuNH and SAANH in 23 
19 and 20 were H-bonded and each 24 membered macrocyclic ring was stabilized by four intramolecular H-bonds (Figure 5). 
Figure 5. Lowest energy structure of 19 (left) and 20 (right) obtained from MD calculations. In summary, cyclo-(Saa1-Leu-Val)2 (19) and cyclo-(Saa2-Leu-Val)2 (20) displayed well-defined distorted “- corner” structures. Such oligomeric assemblies, with intramolecularly hydrogen-bonded structures, can play significant roles in recognizing and binding to suitable ligands mimicking biological systems. CHAPTER II PART-A: Design, synthesis and biological studies of cationic cyclic heterooligomers of furan amino acids. Planar molecules with building blocks that have extended -delocalized systems, which favour the molecules to stack on the face of a guanine quartet are attractive scaffolds to develop new ligands targeting G-quadruplex selectively. Positively charged substituent analogues of parent scaffold that interact with the grooves and loops of the quadruplex, as well as with the negatively charged phosphate backbone are necessary to enhance the selectivity. With these molecular properties, during the past decade, several ligands and scaffolds have been identified or developed that can successfully target G-quadruplex. We have developed a novel furan amino acid, 5-(aminomethyl)-2-furancarboxylic acid and prepared its trimer, an 18-member cyclic oligopeptide, which display a near-planar geometry with cis orientation of all the amide carbonyls. The planarity of the molecules along with aromatic nature of this molecule with cationic side chain allows selective targeting of G-quadruplex. We report here, synthesis and the binding abilities of two cationic analogues each of 18-membered (40 and 41) and 24-membered (42 and 43) cyclic oligopeptides of furan amino acids (Figure 6). 24 
Figure 6: Structures of cyclic peptides 40 - 43 and monomeric units 44, 45. The building blocks used for the synthesis of cyclic peptides 40-43 are the two protected furan amino acids, 44 (Boc-Faa-OMe) and 45 (Boc-Faa(CH2N3)-OMe). The synthesis of 44 was performed by reported procedure (Scheme 10). Scheme 10 N O NO O N O O O H H H X OOHN OO NH HN NH O O O O X X 40: X = NH3+ 41: X = NHCOCH2CH2NH3+ 42: X = NH3+ 43: X = NHCOCH2CH2NH3+ O OMe BocHN O N3 O OMe BocHN O 44 45 D- fructose (46) O H Cl O O OH Cl O O OMe Cl O Jones reagent, acetone, CH2N2, ether, 0 oC, 5 min 85% after two steps 47 48 49 O OMe O O OMe BocHN O 50 44 NaN3, DMF, 65 oC, 1 h i) TPP, methanol, rt, 2 h ii) (Boc)2O, rt, 30 min overall 80% after three steps N3 MgCl2, HCl, Toluene 0 oC, 9 h 
The synthesis of 45 was achieved following the route outlined in Scheme 11. The starting material for the synthesis of 45 was compound 53, which was synthesized easily in two steps following the reported procedures. Compound 53 was transformed into 54 in two steps – deprotection of dicholoroacetyl group with anhydrous ammonia gas, followed by treatment with NaN3 to form the azide 54. Reduction of the azide to amine by catalytic hydrogenatiom with in-situ Boc-protection gave 55. Silylation of 55 was followed by hydride reduction of the ester 56 to give 57. Tosylation of 57 followed by nucleophilic substitution of the tosyl with azide gave 58. Desilylation of 58 with TBAF gave the primary alcohol 59, 25 
which was oxidized to aldehyde 60. Aldehyde was further oxidized to acid and protected as methyl ester to furnish the desired building block 45 (Scheme 11). Scheme 11 OH OH H O + O OEt O i) DMF, 90 oC then Cl2CHCOCl, pyridine, -40 oC ii) NBS, AIBN, CCl4, reflux O O OBr O O Cl Cl H 51 52 53 O O ON3 HO O O ONHBoc HO 54 i) anhy. NH3, ether, -10 oC ii) NaN3, DMF, 65 oC H2, Pd/C(10%), Boc2O, EtOH:EtOAc 95% 90% 55 O O ONHBoc TBSO O OHNHBoc TBSO 56 TBSCl, Et3N, DMAP (cat.), CH2Cl2 DIBAL-H, CH2Cl2, -78 oC i) TsCl, Et3N, DMAP (cat.), CH2Cl2 ii) NaN3, DMF, 65 oC 98% 90% 75% 57 O N3NHBoc TBSO 58 O N3NHBoc HO O N3NHBoc H O TBAF, THF, 0 oC to rt SO3-py, Et3N, DMSO, CH2Cl2 i) NaClO2, NaH2PO4, 30% H2O2 ii) CH2N2, ether, 0 oC 100% 99% 90% O OMe BocHN 59 60 45 N3 O 
With the two building blocks 44 and 45 in hand, the stage was now set to synthesize the peptides. The peptides 40-43 were synthesized following standard solution phase peptide coupling methods using EDCI and HOBt as coupling agents and dry DMF and/or CH2Cl2 as solvents. In the fragment condensation strategy that was followed the Boc-Faa(CH2N3)-OMe 45 was first Boc-deprotected with TFA in CH2Cl2 and coupled with the Boc-Faa-OH as efficiently as with any normal amino acid using the reagents mentioned above to give the dipeptide Boc-Faa-Faa(CH2N3)-OMe (62). Addition of one more unit of Faa in the C-terminus of the dipeptide furnished the tripeptide Boc-Faa-Faa(CH2N3)-Faa-OMe (64). Saponification using LiOH in THF:MeOH:H2O was followed by Boc-deprotection using TFA-CH2Cl2 to get TFA.H-Faa-Faa(CH2N3)-Faa-OH, which was subjected to cyclization using pentafluorophenyl diphenylphosphinate (FDPP) in CH3CN under dilute conditions to 26 
give the desired cyclic product cyclo-[Faa-Faa(CH2N3)-Faa] (65) in 60% yield. The azido group of cyclized product 65, were reduced by catalytic hydrogenation, in a short reaction time to avoid any over-reduction of the furan rings, followed by in-situ Boc protection of the primary amine to give 66. Boc-deprotection of 66 using TFA-CH2Cl2 provided compound 40. Coupling of 40 with Boc-β-Ala-OH afforded compounds 67, which on treatment with TFA in CH2Cl2 gave compounds 41 (Scheme 12). Scheme 12 Dipeptide Boc-Faa-Faa(CH2N3)-OMe (62) on saponification and Boc-deprotection gave TFA.H-[Faa-Faa(CH2N3)]2-OH. Cyclization of this deprotected dimer under similar conditions as described above using FDPP gave the cyclic tetramer cyclo-[Faa(CH2N3)-Faa]2 (68) in 54% yield. Following the above-mentioned procedure cyclic tetramer 42 and 43 were prepared (Scheme 13). O BocHN HN O OMe O O N3 61 CH2Cl2, 0 °C to rt, HOBt, EDCI, DIPEA Boc-Faa-OH, TFA, CH2Cl2 0 °C to rt, 3 h 8 h, 70% O OMe TFA:H2N N3 O 45 62 O BocHN HN O OH O O N3 LiOH.H2O, THF:MeOH:H2O (3:1:1) 0 °C to rt, 3 h 63 O BocHN HN O O N3 HN O OMe O O 60% 40 N O NO O N O O O H H H N3 CH2Cl2, 0 °C to rt, HOBt, EDCI, DIPEA Boc-Faa-OH, 8 h, 70% i) LiOH.H2O, ii) TFA, DCM iii) FDPP, DIPEA, CH3CN, 20 h N O NO O N O O O H H H BocHN H2, Pd/C(10%), Et3N Boc2O, MeOH:EtOAc TFA-CH2Cl2 100% N O NO O N O O O H H H Boc--Ala-OH, EDCI, HOBt, CH2Cl2, then 40, DIPEA, CH2Cl2 TFA-CH2Cl2 100% HN BocHN O 41 64 65 66 67 70% 27 
Scheme 13 Biological Studies: Biophysical Characterization The binding of these four (40-43) newly synthesized cationic cyclic peptides containing furan amino acid (Faa), with quadruplex DNA over duplex DNA were followed by Surface Plasmon Resonance (SPR), Fluorescence Resonance Energy Transfer (FRET) and Differential Scanning calorimeter (DSC) study. Comparative results of these experiments are given in the Table 1. OOHN OO NH HN NH O O O O N3 N3 O BocHN HN O OMe O O N3 i) LiOH, THF:MeOH:H2O ii) TFA-CH2Cl2 iii) FDPP, DIPEA, CH3CN 54% 62 68 OO NH OO NH HN NH O O O O NHBoc NHBoc 42 69 H2, Pd/C(10%), Et3N Boc2O, MeOH:EtOAc OOHN OO NH HN NH O O O O HN NH O OBocHN NHBoc 43 Boc--Ala-OH, EDCI, HOBt, CH2Cl2, then 42, DIPEA, CH2Cl2 70 TFA-CH2Cl2 100% TFA-CH2Cl2 100% 28 
Table 1: Dissociation constants, KD (M) determined by SPR and differential melting temperature, TM, (C) determined by FRET and DSC.a Parameter 	DNA 	40 	41 	42 	43 
KDa 	Telo 	29 	21 	14.5 	3.1 
Hairpin 	950 	700 	nd 	nd 
TMb 	Telo 	9.0 	10.0 	12.0 	17.0 
Telo in presence of competetor 	7.0 	7.0 	12.0 	17.0 
TMc 	Telo 	2.0 	3.0 	6.6 	9.2 


